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LAPINONE. A NEW ANTIMALARIAL*
By  I.OU IS F. .F IE S E R
Sheldon Emery Professor of Organic Chemistry, Harvard University
Iv&pinone is an antitnalarial of novetj chemical type and unsual physio­
logical properties. It is a hydroxyalkyljftaphthoquinone composed of only 
carbon, hydogen, and oxygen, and hence' it is of simpler composition than 
all other known antimalarials and, indeed| than any other chemotherapeutic 
agent. f
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Quinine is a 6-mcthoxyquinolinc derivative with a nitrogen-containing 
side chain at position 4. Atabrine, the synthetic substitute suppressive 
introduced by the I. G . Farbenindustrie (1930), is an acridine derivative, 
but it is related to quinine in that the first two rings constitute a 6-methoxy- 
quinoline unit with a nitrogen side chain at the 4-position. The other 
I. G . Farbenindustrie drug plasmochin (1926), now oflen called pamaquine 
in the United States, has the atabrine side chain moved to the 8-position of 
6-methoxyquinoline ; it is an 8-aminoquinoline derivative. The new 
American drugs pentaquine (Drake and co-workers, 1946) and primaquine 
(Elderfield aud co-workers, 1946) are related 8-aminoquinolines with small 
variations from plasmochin in the structure of the side chain ; thus 
primaquine is simply plasmochin minus the two N-ethyl groups. These 
8-aminoquinolines have little suppressive action, but when administered in 
conjunction with quinine they eflFect a high percentage of cures of relapsing 
vivax malaria. Plasmochin is too highly toxic for safe use ; the status of 
the newer substances in this respect is still uncertain. Among a large 
number of other compounds synthesized, the Germans prepared the 
4-aminoquinolines santochin and the substance now known as chloroquine, 
but their pharmacologists did not rate the compounds very highly. American 
research showed that chloroquine is a very effective suppressive and led to
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the iiilrodution of the related catnoquuie (Burckhalter, et al., 1948). The 
4-aminoquiuoliues are sui^pressive only and lack curative properties. The 
same is true of the biguanide derivative palndrine (Curd, Davey and Rose, 
1945)1 developed in Knglaud by 1 . C. I. workers.
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A ll of these antimalarials, natural and synthetic, contain nitrogen, and 
$ofn9 contain chlorine as w e ll; lapinone contains neither nitrogen nor
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chlorine. The sulfa drugs and penicillin are also of elaborate composition* 
since they contain carbon, hydrogen, oxygen, nitrogen, and sulfur.
Lapinone functions by a mechanism evidently different from that of any 
other antimalarial. It destroys malarial parasites by inhibiting a respiratory 
enzyme of parasitized cells. Tlie naphthpqtrinouc seems of particular interest 
because of indications that it has high potency as both a suppressive and 
curative drug. .
I,apinone resembles vitamin K j in'elesnentary composition, structure, 
and physical properties. Both substance^ arc 1,4-uaphthoquinoncs, and both
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a rc  lip id -so lu b le , w ater-in so lu b le, v isco u s y e llo w  oils. T h e  an tim alaria l has 
a t th e  2-i^osition a h y d ro x y l g ro u p  f rid at the 3-positiou a 19-carbon side 
ch a in  c o n ta in in g  a h y d ro x y l g ro u p  ; the v ita m in  has a 2 -n ielh yl g ro u p  and 
th e  su b stitu e n t a t p osition  3 is a 20-carbou side chain  co n ta in in g  a d ou ble  
b o n d .
The development of tlie new antimalarial resulted from systematic 
exiiloitation of a fortuitous cine uncovered in the extensive lU'Ogram of 
antimalarial research sponsored by the United States government during 
World War II and organized by the Committee on Medical Research of the 
C^ Efice of Scientific Research and l^evelopment. In this program of the
C . M. R., some thirty .nine chemical research groups operated under govern­
ment contract in coordination with pharmacological and clinical research 
groups. t)ne line of investigation was the synthesis and biological documenta­
tion of all conceivable isomers, derivatives, and analogs of the known 
_antimalarials of the quinoline and acridine series ; such work led to the 
development of camoquine, pentaquine, and primaquine and to recognition of 
the value of chloroquine. The second line of attack consisted in the biological 
screening of organic chemicals of a wide variety of types in the search for 
antimalarials of a new kind. In one such screening program, chemists, of 
the Abbott Laboratories in North Chicago visited some of the larger universi­
ties to collect and code miscellaneous research samples and send them to the 
pharmacological group of Dr. Arthur P. Richardson at the University of 
Tennessee Medical School at Memphis for screening assays against Plasmodium 
lophurac in ducks. O f several hundred compounds assayed* all but three 
proved to be complete^  inactive. The three active compounds, which 
possessed definite if weak antimalarial activity* were related nai^thoquinones 
that had come frem my laboratory at Harvard and that I had taken from
a collection af lapachol samples bequeathed to me by Samuel C. Hooker on 
his death in 1935. The most interesting of the three compounds was hydro- 
lapachol, the dihydro derivative of lapachol.
Samuel C. Hooker (18S9-1896 ; 1915-1935)
L . F. Fieser
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Lapachol* a yellow pigment that occurs in the grain of certain tropical 
woods, had been the subject of a remarkable series of researches by the 
Hnglish-born chemist Hooker, a masterful experimentalist whose lot was 
cast in the field of American sugar technology, in which he achieved brilliant 
success. A  romance with an American girl student at Munich had led 
Hooker to come to the United States, where, finding no suitable academic 
posts open, he had accepted employment in a sugar refinery in Philadelphia. 
Hearing of the presence in the city of a young German-trained chemist, a 
Philadelphian manufacturer of fine fishing rods and bows and arrows from the 
rare Bethabarra wood, imported at considerable expense from South America, 
consulted Hooker about the possible utilization of the yellow pigment of the 
wood, and provided the young chemist with quantities of Bethabarra sawdust 
and waste cuttings. Hooker found the chemistry of lapachol a fascinating subject 
for spare-time research, and in the period 1889-1896 he published a series of 
brilliant papers reporting the complete elucidation of the structure of lapachol 
and a description of an amazing array of novel reactions of the interesting 
substance [Greene and Hooker (1889.) ; Hooker and Greene (1889); Hooker 
(1892, 1893, 1894, 1896) ; Hooker and Gray (1893) ; Hooker and Carnall 
(1894); Hooker and Walsh (1894) > Hooker and Wilson (1894)]. In 1896, 
although he had not completed the research and bad stated in his last papet
that “ I shall hope to return to the consideration of this problem in the future”  
he felt obliged to abandon this side-activity and devote his whole energies 
to the professional field of sugar technology. His efforts in this direction 
were eminently successful ; he introduced the beet sugar industry into 
American practice and achieved so many other successes that he eventually 
rose to the post of executive vice-president of his company. But he had not 
forgotten lapachol, and he was ever conscious of the promise of further work 
stated in his last paper. So, as soon as|be had acquired an adequate compe 
tency. Hooker retired from the sugar ^business in 1915, built a private 
laboratory in the former stable in back of ibis elegant residence in Brooklyn, 
and shortly resumed the lapachol research exactly where he had left off 
in 1896. j
It was my good fortune to meet |>r. Hooker in 1926 and to be in close 
association with his scientific work until fbe time of his death. I had applied1'
techniques of oxidation-reduction potential measurements learned in my 
work for the Doctorate under Professor James B. Conant [Conant, Kahn, 
Fieser and Kurtz (1922/; Conant and Fieser (1922, 1923, 1924)] to
studies of heterocyclic quinones [Fieser I1926) ; Fieser and Ames (1927) ; 
Fieser and Peters (1931) ; Fioser and Hartwell (1935); Fieser and Kennelly 
(1Q35); Fieser and Martin (1935)! and polynuclear quinones, [Fieser (1929;) 
Fieser and Dietz (1931)] and to an investigation of the tautomerism of 
hydroxyquinones [Fieser (1928, 1929); Fieser and Fieser (1934); Fieser 
and Thompson (1939)]. Through Dr. Hooker’s generosity in supplying me 
with samples, I was able to include 16 quinones of the lapachol series in 
my potcntiometric study of tautomerism.
I was fascinated by my contacts with this elderly gentleman who 
appeared to me to be an extraordinarily gifted experimentalist and a rare 
personality. H aving lost contact with the academic chemists of his own age. 
Hooker was glad to have a young friend enthusiastically interested in his 
beloved lapachol chemistry. On his death in 1935, I edited a series of eleven 
posthumous papers reporting his researches of 1915 to 1935, [Hooker (1936); 
Hooker and Steyermark (1936); Hooker and Fieser (1936)] and I was 
bequeathed his extensive collection of beautiful samples of compounds 
derived from or related to lapachol.
When Richardson’s assays revealed antrirralarial activity in the relatively 
simple naphthoquinone hydrolapachol, I was rn a particularly favorable position 
to investigate this new clue. In conducting the potcntiometric investigations 
cited above I had acquired experience with practically all the known methods 
for the preparation of naphthoquinones and had introduced a few new proce­
dures. Inspired by my association with Dr. Hooker, 1 had achieved the first 
synthesis of lapachol. (Fieser, 1927) M y student Jesse T . Dunn had 
synthesized plumbagin in 1936 (P'ieser and Dunn, 19361 and 1 had 
synthesized vitamin K , in 1939 (Fieser, 1939, 1940). M y associates and I 
had developed other syntheses in the naphthoquinone [Fieser, Campbell,
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Fry and Oates (1939); Fieser and Weighard (1940); Tishlcr, Fieser and 
Wendier (1940); Fieser, Gates and Kilmer (1940); Fieser and Gates (1941); 
Fieser and Jones (1942); Fieser, Turner (1942); F'ieser and Turner (1947)]» 
phenantbrenequinone (Fieser, 1929), authraquinone (Fieser and Fieser, 1935) 
aud i,2*benzanlhraquinone (Fieser and Dietz, 1929) series, and we had 
investigated a number of interesting reactions of quinones. [Fieser and 
Peters (193I1 1935): P'ieser (1931'; Fieser and Seligman (1934^ Fieser and 
Hartwell (1935); P'ieser and Dunn ^^ 1936, 1937); Fieser, Hartwell arid
Seliginan '1936I; P'ieser and Bradsher (1939); P'ieser and Fieser (1939, 1941)]. 
Of particular importance to the problem at hand was the timely discovery with 
P'. C. Chang aud A . It. i )xford of the method of peroxide alkylation (p'ieser 
and Chang. 1942; Fieser and O xfoid, 1942), whereby hydroxy naphthoquinone 
is converted into a 2-hydroxy-3-alkyl-i,4-na phlhoquinone by reaction in 
acetic acid solution with the peroxide of an acid. This convenient one- 
step process provided a quick method for the synthesis of a large number
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of substances of the hydrolapachol type having hydrocarbon chains <R) of 
varying length and including straight chain structures, chains with branches 
at various points, and chains containing aromatic and alicyclic rings.
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A  second general method that [>roved of great use to us was a remarka­
ble oxidation discovered by Dr. Hooker, the Hooker oxidation (Hooker, 
1936). Hooker had discovered that a hydroxyalkylnaphthoquinone can be 
converted into the next lower homolog by oxidation with alkaline 
permanganate in the cold, and he had found that the mysterious disappea­
rance of the methylene group occurs eVen in the case of lapachol witl)out 
disturbance of the double bond. He h|id synthesized the derivative with a 
seven-carbon side chain and degraded it seven Hooker oxidations to every 
one of the lower homologs. The reac^on was of great service in our
V *
synthetic program; for example, the rd|bdily available even-carbon acids 
afforded, by peroxide alkylation, the seri^ of qttinones with Cn, C n, Cjs, etc. 
side chains, and Hooker oxidation of the? products then yielded the other­
wise inaccessible homologs with Cs, C|o, C u , etc. side chains. Hartwell, 
Seligtnan and I (Pieser, Hartwell Seligtnan, 1936) had made a
preliminary stiidy of the mechanism ot the Hooker oxidation, and in IQ40 
Mary Pieser and I discovered an intermediate in the reaction and she had 
subsequently established its structure. When, later, the reaction became 
of importance to onr synthetic program, I worked on the experimental 
procedure and was able to clev.dop a high-yield two-step process that is 
applicable to large as well as small quantities and represents a distinct 
improvement over the ori.ginal one ^Pieser and P'ieser, 1948!.
M y researcli group, which eventually was expanded to a total of thirteen 
chemists, plunged into the work of exploring variations in the naphtho­
quinone structure and synthesized a total of some .>50 new quiiiones. Xhe 
Abbott Laboratories joined us in the initial synthetic program, and a group 
of five of their chemists under the direction of Dr. Marlin T , Leffler 
synthesized an additional 75 quinones for bioassay. The total effort reported 
in a series of eight jonit papers ll'Mescr cl al , 1948) included al.so the 
prejjaration of 46 quinonc derivatives and of a considerable number of new 
intermediates. One of my co-workers. Dr. W. O. Dauben, completed 
some of the synthetic work at the University of California in Berkeley. 
Another, Dr. P)rnst Berliner, spent his summers in Cambridge and continued 
the synthetic work during term lime at Bryn Mawr, with the collaboration 
of his student Frances Bondhus, now Mrs. Berliner. My Ph. D. students 
Armin G. Wilson and Evelyn Hodes were married in the course of the work. 
Finding some periods of respite from my wartime activities in the develop­
ment of new incendiary munitions, 1 had the pleasure of personal 
participation in various phases of the experimental program and worked 
out procedures tor the preparation of several of the key naphthoquinones 
and intermediates on a practical scale by a diene synthesis (P'ieser, 1948).
Interest in the naphthoquinones as antimalarials was greatly enhanced 
when cooperating workers of the Rockefeller Foundation found that the 
substances not only suppress malarial infections in chickens but are effective 
prophylactic agents [Clarke suxl Theiler, I1948); Whitman, (19481J. In 194^
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these investigations established that the naphthoquinone drugs effectively 
destroy both the trophozoits of the red blood cells and the exoerythrocytic 
forms of malaria parasites found in the reticulo-endothelial cells of chickens 
infected with Plasmodium gallinaceum. Quinine and atabrine suppress 
the trophozoites, but exert no control whatever over the exoerythrocytic 
forms. These observations strongly suggested that the naphthoquinones 
would exhibit curative as well as suppressive action, and such an effect was 
subsequently established in three different avian infections. Walker and 
Richardson ^1948) and Walker, Slanber and Richardson (1948) later observed 
a very interesting synergistic or potentiating effect of a naphthoquinone and 
the 8-aininoquinoline derivative plasmochin (pamaquine) ; a combination of 
one/tenth the curative dose of each drug resulted in roo% cures.
The program of synthesis by our chemical groups, coupled with prompt 
and able bioassays by Dr. Richardson’s groui> in Memphis, soon outlined 
rough relationships betw'een chemical constitution and biological potency 
(Fieser and Richardson, 1948). We were eventually able to produce com- 
l>ounds possessing no less tlian one hundred times the potency of hydro- 
lapachol, the compound that had given the principal clue to the new develop­
ment. The assays for suppressive activity against Plasmodium lophurae 
in ducks were expressed in terms of the effective dose, in mg. of drug per 
kg. of body weight, required to effect 95% reduction of parasitemia, re­
presented by the symbol HDna. For hydrolapachol, ED!,r. =  6S m g./kg., and 
hence the substance is only about one-seventh as active as quinine (base), 
ED„o= 10.25 m g./kg. The most active naphthoquinone encountered had 
the high potency EDu:, =  o.67 m g./kg., but the compound was available only 
by a very difficult synthesis.
In 1943 an initial clinical trial was conducted at the Goldwater Memorial 
Hospital in New Y oik on syphilitic patients undergoing malaria therapy 
(Wiselogle, 1946). Each cooperating laboratory supplied for the trial the
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most promising naphthoquinone that could be produced in a hurry in adequate 
quantity (250 g . ) ; these were the substances coded as M-285 (Abbott) and 
M-X916 (Harvard), whose structures and activities are shown in the chart. 
Although M-aSs is four times as potent in the duck assay as M -tgid, it 
proved to be completely inactive in five patients (blood-induced P, vivax and
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P. f^eipAtum), whereas “M^xgiS produced m temporary suppression ai fevef 
e:kte^ditig fct sn average of 9.5 days i|i eight cases. The effect tiot 
aatlsfattoty, but enough to show that ^ -19 16  has definite antimalatial 
activity in man. |
The resQlts were very disappoiutiiij The medical authorities of the 
C M R  felt that the uaphthoquinoues had. been given a fair trial and had 
failed, and they discouraged us from co^inuing the study ; they pointed to 
other instances where results in animals a^il to carry over to man. The  
Abbott I^aboratories grroup merely finisl^d off such synthetic work as they 
had in hand. But my group was not satisj fed. We did not like to rest the 
ease without trying to find out why impounds so active in ducks and 
chickens proved inactive, or only weakly active, in man. We were- parti­
cularly intrigued with the curious reve||5al in activity; why is M-aSs, so 
potent in ducks, completely inactive in inaf whereas M -i9i6, the weak sister 
in the duck assays, exerts a mild lheiapeu|ic effect in tiian ?
So some of the chemists of my g r ^ p , particularly Dr. Hans Heyraann 
and Dr. Frederic C. Chang, became bioch4mists and plunged into the problem 
of investigating the metabolic fate of naphthoquinones administered to 
nonmalarial human subjects (Kicser aud others, 194S). W^ e soon despaired 
of the idea of obtaining supplies of urine from the subjects of the clinical 
trial or of surmounting the governmental red tape involved in obtaining 
conscientious objectors as subjects, and initiated the study by eating the 
compounds ourselves. I participated in this phase of the work by consuming 
a total of 33 g. of various naphthoquinones and working up all the mines 
and several, plasma samples; it was a thrilling experience to have bVOod 
from my arm aud spun down, and t6 look at the raspberry red plasma 
containing metabolites and know that my own liver had accomplished the 
metabolic oxidations concerned. Later, after returning on VE-day from 
participation in the Alsos Mission of scientific intelligence that accompanied 
our armies of conquest in Germany, I enjoyed a period of freedom from both 
\Var work and teaching and as able 10 carry out in the test tube some of the 
oxidative changes that had occurred in my liver (Fieser, 1948).
" After an initial start in which we chemists served as our own guinea 
pigs, Df. Arnold M. Seiigman came to our aid and provided subjects for 
study of drug metabolism from the Beth Israel Hospital. He instituted the 
ingenious practice of administering some of the compounds to polycytheittic 
^ tie n fs  prior to the drawing of the necessarily large vo lu m e of blood in 
order lo provide us with amounts of plasma adequate for isolation of meta- 
boHtes feom this souroe ; in several instances the metabolites extracted from 
{dhsuitt war* found to be identical with those excreted in the uniio^ 
re^ irad was ably dene at the Harvard M e d ia l School b y
OtiW Krayer, Dr. E . B- AstwoOd# and Dr. A . M. Seiigman.
hxpiratkm war-thne contract,' wefts centltimiid
' mjiffy Kotkafell^ FoUndatirm, wo found'tl»4
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of the naphthoquinones in man consists in oxidative attack of the hydrocarhoa 
side chain. Thus the side chain of hydrolapachol, — CHaCHaCH(CHa)*, 
metabolized to -CHaCHaC(OH){CH3)2 ; the product was identified by com­
parison with a sample of hydroxy hydrolapachol taken from the Hooker 
collection. Hooker’s samples were of the greatest service in develoi>ment 
of colorimetric methods for separating and identifying various alcoholic and 
unsaturated derivatives of the naphthoquinones (Fieser, 1948).
In all, some eight crystalline products of metabolism w’ere isolated and 
their structures established. ^Ve found that M-285 is metabolized to a 
carboxylic acid and that M -igtd is metabolized to two hydroxy derivatives, 
as shown in the formulation above, but the substances were isolable only 
on a micro scale and not in quantity sufficient for bioassays. W e had 
submitted a few synthetic compounds with oxygenated side chains and they 
had all been found devoid of activity. “  What substance,” we kept asking 
ourselves, “  was responsible for the weak therapeutic effect resulting from 
administration of M -ig id ? ” Dr. W . B. Wendell ^^ 1946) at Memphis had 
discovered that the naphthoquinones are very powerful inhibitors of respira­
tory enzymes and are effective at dilutions in the order of i x io~*M. The 
antirespiratory activity of a given member of the series, relative to that of a 
reference standard, can be measured on a micro scale in a Warburg apparatus 
by determining the concentration required to half-inhibit the respiration of a 
suspension of parasitized red blood cells drawn from a duck infected with 
P. lophurae. By the spring of 1945 W endell’s results so strongly suggested 
that the convenient i n  v i t r o  determination of antirespiratory activity affords 
a reliable guide to in  v i v o  autimalarial activity that we decided to install 
the in vitro test in our own laboratory for the more precise study of drug 
metabolism. This meant establishmeut and maintenance of a colony of 
malarial infected ducks, housed under some protest in the biological labora- 
tory, and installation and operation of a Warburg apparatus in our own 
laboratory. The senior chemist of my group. Dr. Hans Heymann, rose to 
the occasion of mastering the many biological and biochemical techniques 
involved and ably conducted an extended series of antirespiratory studies, 
[Heymann and Fieser (1948) ; Fieser and Heymann (1948)]. Determinations 
of the relative anj-irespiratory activities of 76 naphthoquinones in Memphis 
and of 8a in Cambridge showed conclusively that the in viito test is a safe 
measure of in vivo activity.
The micro test permitted study of the course of metabolic drug deacti­
vation in the following manner. A  given compound was administered to ^ 
patient by I^. Seligman, usually intravenously, and small blood iumples 
were drawn from time to time, spun down, and the plasanas sent over to Dr- 
Heymann in Cambridge, Since oxygenation of the side chain does not alter 
the charomephoric properties of the naphthoquinone nucleus, colorinietric 
determinatkm of the pigment extracted from a plasma ^ v e  the vidua of total 
fw^ldip^ntn<cmdi;d^pade<land (<^ ) onda^taded. AamaU sample)!^ pigment
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was th6n put into the Warburg machiue, and a determination made of'tb'e 
ahtirespiratory activity j^r colorimetric equivalent of pig:meut as comi»ared to 
that of the drug administered:. Naphthoquinones of all of the types initially 
available proved to be metabolized coinpletely within 3-4 hours. In  
most cases the initial activity, however 1 ligl^ was completely lost in the 
process. This was true of M-285, and an ^ vitro test of the carboxylic acid 
rrietabolite that we had isolated show’ed to be completely inactive. The  
case of M-1916 was different. Here, mefabolic change was as rapid as ever 
but the activity dropped, in four hours, !o a level one-tenth that of M-1916 
and then persisted at the same level for soq |e twenty hours. The two Iiydro- 
xylated metabolites that we had isolated jtere then found, in repeated trials  ^
to possess antirespiratory activity just odt-tenth that of M-1916. W e thus 
reached the conclusion that the weak ana imalarial action of M -i9i6  in the 
clinical trials must have been due to the wtpikly active but persistent hydroxy 
lated metabolites. A  hydroxyl group in t| e side chain provides protection 
against metabolic attack but, at least in th^ case of M-1916 and the few other 
compounds that we had then investigate, the introduction of a hydroxyl 
group into the side chain detracts very materially from the potency of the 
parent compound.
However, our program of systemmatically investigating all types of side 
chains eventually afforded results suggesting that the deactivating influence 
of oxygen substitution can be offset by an increase in the carbon content of 
the side chain. We were later able to rationalize this empirical finding by a • 
physico-chemical study of distribution characteristics. Richardson’s, assays 
had shown that in any homologous series, for example hydroxynaphtho- 
quinoues with n-alkyl-, isoalkyl-, w-phenylalkyl-, or co-cyclohexylalkyl-side 
chains,* biological activity increases with increasing molecular weight for a - 
time, passes through a maximum, and then falls off. However, the optimum , 
molecular weight varied considerably from one series to another; in the n-alkyl 
series a C»-side chain afforded optimum activity, whereas in the w-cycloalkyl 
and w-phenylalkyl series highest potency was reached with C,i>_x, and C»«- 
side chains, respectively. These relationships became clear from a study of 
the distribution of the naphthoquinones between ether, in which the free acid 
dissolves with a yellow colour, and aqueous buffers, which extract a certain 
amount of the red anion (Fieser, Kttlinger and Fawaz, 1943). By colori­
metry, it is a simple matter to make an accurate determination of the constant 
/»B, which characterizes the balance of hydrophilic-lipophilic properties of a 
given member of the series. This constant is defined (sec equation) as the 
pM of an aqueous buffer
___ , __[Quinone in ether layer] ^ '
[Quinone in water iByearJ
capable of extracting just i/iox-part of pigment from an equal volume qt 
etSier. In each series increases with increasing molecular weight, aiid the
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cufves for the different series are parallel. The effect of the introdncttQt) 
cyclohexyl and phenyl groups into the side chain is tp produce progressive 
shifts in the direction of increased hydrophilic character. These shifts fPHow 
closely the displacements in the peaks of antiraalarial activity from series to 
series, and the compounds of highest activity in the differtmt series all have 
Pk values in the range 10-12. ' Thus a naphthoquinone, to possess high bio>. 
logical potency, must have a balance between hydrophilic and lipoyhilic 
propet ties corresponding to a pu of this favourable range.
A  hydroxyl group in the side chain, desired for protection against 
metabolic attack, very greatly enhances the hydrophilic character of the 
molecule; the effect amounts to a displacement in pH of about 4 units.
is close to being the peak compound in its series, but the bydroxyi 
group in the metabolites reduces pH to an unfaborably low level- However, 
an appropriate increase in the molecular weight should compensate for the 
hydrophilic shift caused by the hydroxyl group. We therefore decided to 
try to synthesize a naphthoquinone with a hydroxyl group substituted in a 
very large hydrocarbon side chain. A t the time this pioject was taking 
shape we had the pleasure of the addition to our group of Dr. George Pa^az, 
on leave of absence in 1945-1946 from the Department of Chemistry of the 
American University of Beirut, Labanon, and novv Professor of Pharmacology 
at Beirut. Dr. Pawaz, who with the able assistance of his wife Eva, parti­
cipated in the distribution study cited, undertook the synthesis of a compound 
of the type specified and, by application of a method developed by Dr. 
Heymann for the synthesis of a similar model compound, synthesized the 
compound coded as M-2350, now designated lapinone. He synthesized three 
rela'ted homologs, but they proved less promisiug. Eater, three Ph.D. stu­
dents synthesized a large number of analogous quinones with hydroxylated 
side chains, and with side chains containing ketonic, oxide, sulfide, and 
nitrogen functions [Cram (1949); Paulshock and Moser (1950); Moser and 
Paulshock (1950)] but most of these compounds proved to be much less 
potent than lapinone and none seem more promising. The first guess was 
thus a lucky one..
M-2350, lapinone, was initially assayed by Dr. Richardson by the usual 
route of oral administration atid found to be only inodemtely active. I 
thenght this might be due to poor absorption from the gut of this compound 
of high molecular weight and asked for a reassay. Suroly enough, intramus.< 
cularly administered material proved to possess the high antimalarial potency 
that we had predicted. We then, hopefully, investigated the resistance of 
the substance to metabolic deactivation in the human body. Dr. Seligman 
adtoinistexed the compound intravenously to patients of the Betb Israel 
Hospital and Dr. Heymann determined the residual activity of extracted 
plasma pigments (Fieser. Heymann and Seligman, 1948). The results were 
very encouraging, Unlike M-a8s, and all the other nephlhoqniimaea
with hydita^ jsrboiak side clmins, laj)|none retained a large mefumre pf its erjginal
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psts, it appeared that the goal of 
»ncy and of adequate resistance tp 
Sieved. We thus awaited with greajc 
lie clinical trial conducted by Dr. 
liversity at Beirut. Nine patients 
given 2 g. of lapinone day fot 
Inline solution. All patients were 
sod was freed of paiasitcs. Thus, 
irts a fully satisfactory suppressive 
chickens: The result showed that 
corrected and it justified our sus-
actlvity for periods of 20-40 hrs, after jad>ninistration. l ‘fae results were 
substantiated by experiments with animal  ^of seven species. Mice inetaboUae  ^
M'Xpifi more nearly like humaus than '^ o any of the six other test snitndls 
studied, and lapinone administered to mi|^ shows good retention of entires* 
piratory activity.
By the criteria of the laboratory 
developing a naphthoquinone of high pc 
metabolic deactivation in man had been ac 
intOtest the outcome of an initial, small 
Fawaa on his return to the American 
infected with primary vivax malaria weJ 
four days by intravenous injection in gf 
relieved very promptly of fever and the 
unlike M-285 and M-1916, lapinone ex4 
action in man iust as it does in ducks anc 
the defect in the early compounds had be 
tained effort to solve a problem in chemotherapy through a program of 
rational research aimed at understanding the fundamental phenomena 
involved. The Lebanese clinical trial was planned merely as a test for sup­
pressive action in man, and the period of administration was not at all 
comparable to the 14-day regime employed in the standard test for curative 
action. Nevertheless, six of the patients treated had gone without relapses 
when last checked after periods of from thirteen to fifteen months after termi­
nation of treatment. The result tentatively suggests a carry-over to man of 
the curative action of other naphthoquinones observed in birds;
More recently, Dr. Alexander M. Moore of Parke, Davis and Co. has 
reported results of a reliable new test for supperssive and curative action 
against P. lophurae in white leghorn chicks that he had previously applied 
to ail the standard antinialarials and to several of the newer compounds. 
In a letter of January 3, 1951, Dr. Moore states that : “ As a suppressive, 
lapinone was about three times as active as quiiiiue, i. e. EDus ca. 5 mg./kg, 
daily for 4 days, when administered intramuscularly. As a curative agent, 
lapinone was highly effective' when administered intramuscularly at the 
maximum tolerated dose. Of all the types of 'antiraalarial drugs tested, 
only the 8-aminoquinolines and the 2-bydroxy-3-alkyl-i, 4-naphtboquiiiQnes 
have cured young chicks infected with lophurae malaria. Although the 8-aminoquinoliues cured ouly a fraction of the infected birds, lapinone was 
much more effective. Indeed, you will observe from the attached reports 
that lapinone cured every one of the infected birds. No other substance tested in this laboratory to date has proved so effective in the curative test.”
Lapinone thus appears promising enough to warrant further phartnacolo* 
gical study and clinical evaluation. A  practical synthesis from ^-uaphthol 
and sebacic acid was reported in 1950 (Pawaz and Fieaer, 1950)- Bndo 
Products Inc. <d New York has initiated manufacture of lap|uOne« at least
u L. F, Fies&r
on a scale adequate foi pharmacological ami clinical evaluation. Since thfe 
sobatance is a water-insoluble oil  ^ in our 1a,boratC»it^  teats and in the I;»ebadese 
trial it was administered by intravenous or intraknuscular* injection in wder 
to by-pass the question of efficiency of absotbiion from the intestines. 
However, Dr. Nathan Weiner of Kndo Products has recently developed 
a promising formulation for oral administration and is investigating its 
efficacy.
1 hope th it some of the many able medical scientists of India will apj>ly 
their knowledge, experience, and vast test materia] to the study of this new 
compound. It would be very gratifying if our own prolonged research, 
as w'ell as the early fundamental invesiigations of Dr. Hooker, should, turn 
out to be of some service to the people of this great country, where malaria 
is still a major problem.
^Solution for intravenous injection (developed by I>r. A. M. Seligman): dissolve a g» 
of lapinone in 50 cc. of alcohol and add all at once with agitation a solntion prepared 'from 
r^ oo cc. of physiological saline, 200 cc. of 6% Knox pyrogen-free gelatin solution {pH 7.4), 
end 1.2 g. of sodium carbonate monohydrate ; the solution should not be prepared more 
than a few hours before required for injection.
SoWfion for intramuscular injection (devotoped by Dr. George Pawaz): dissolve 5 g. 
of I'epinone in 13 cc. of sterile peanut oil and to the solution add a solntion of 0.2 g. of 
Bntescin H*NC#H4COiC<H»—f>) in 2 cc. of ether.
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